Pharmaceuticals

Soft Mist Inhalers Market to Reach $4.15 Billion by 2029, Growing at a CAGR of 7.9%

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Soft Mist Inhalers Industry Expected To Reach By 2029, Starting From 2025 Levels?

The soft mist inhalers market size has demonstrated robust expansion in recent years. This market is projected to expand from $2.84 billion in 2024 to $3.06 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. Historically, this growth has been driven by factors such as the rising incidence of respiratory conditions, increased uptake of inhaler devices for managing asthma and COPD, heightened awareness concerning healthcare, the escalating need for sophisticated medical remedies, and enhanced healthcare spending and accessibility.

The soft mist inhalers market size is projected to experience substantial growth over the coming years, reaching $4.15 billion by 2029 at a compound annual growth rate (CAGR) of 7.9%. This anticipated expansion during the forecast period can be attributed to several factors, including escalating global pollution levels, an expanding geriatric population, a rising incidence of asthma and COPD, increased adoption of non-invasive drug delivery methods, and the developing healthcare infrastructure in emerging markets. Major trends anticipated in the forecast period encompass a growing demand for portable and easy-to-use inhalers, a focus on eco-friendly and sustainable inhaler designs, increasing integration of digital health solutions with these devices, a shift towards personalized and patient-centric treatments, and ongoing advancements in drug delivery technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24403&type=smp

Which Drivers Are Supporting Growth Of The Soft Mist Inhalers Market?

The increasing occurrence of asthma is anticipated to drive expansion in the soft mist inhalers market. Asthma, a persistent respiratory ailment, leads to airway inflammation and constriction, complicating respiration. This surge in asthma cases primarily stems from greater exposure to air pollution, which worsens respiratory issues and progressively damages lung function. Soft mist inhalers aid in treating asthma and other chronic obstructive pulmonary diseases by delivering a gentle, slow-moving medicated mist straight to the lungs, enhancing drug delivery and providing breathing comfort with little user coordination. For example, data from December 2023 by the Australian Bureau of Statistics, an Australia-based government agency, showed that in 2022, roughly 2.8 million people in Australia, representing 10.8% of the population, had asthma. Additionally, one in three people with asthma (33.9%) reported taking their asthma medication daily. Consequently, the growing prevalence of asthma and chronic obstructive pulmonary disease (COPD) is stimulating the growth of the soft mist inhalers market.

What Are The Major Segment Categories Driving The Soft Mist Inhalers Market Growth?

The soft mist inhalers market covered in this report is segmented –

1) By Product Type: Portable Soft Mist Inhalers, Stationary Soft Mist Inhalers

2) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory Diseases, Other Applications

3) By End-User: Hospitals And Clinics, Home Care Settings, Other End-Users

Subsegments:

1) By Portable Soft Mist Inhalers: Handheld Reusable Soft Mist Inhalers, Disposable Single-Use Soft Mist Inhalers, Compact Travel-Friendly Inhalers, Pediatric-Use Portable Soft Mist Inhalers

2) By Stationary Soft Mist Inhalers: Homecare-Use Stationary Inhalers, Hospital-Grade Soft Mist Inhalers, Integrated Nebulizer Systems, Long-Term Therapy Devices

What Key Innovation Trends Are Fueling Advancements In The Soft Mist Inhalers Market?

Major companies within the soft mist inhalers (SMIs) market are prioritizing strategic collaborations to broaden their market presence and improve the accessibility of their offerings. These firms aim to leverage complementary capabilities and gain a competitive edge in delivering innovative, patient-centric inhalation therapies by partnering with research institutions, technology companies, and regional healthcare providers. For instance, in 2024, Merxin Ltd., a UK-based company specializing in the design and supply of generic and customized inhaler devices, collaborated with OECHSLERhealth, a Germany-based manufacturer of medical devices, to launch the Soft Mist Inhalers (SMI) Powerhouse. This innovative initiative is designed to accelerate market entry for drug developers. It involves a strategic alliance with OECHSLER Health, combining its manufacturing and assembly expertise with Merxin’s proprietary SMI design. Together, they aim to establish new industry standards for intellectual property protection, performance, reliability, speed, and cost-effectiveness.

Who Are The Major Companies Operating In The Soft Mist Inhalers Market?

Major companies operating in the soft mist inhalers market are Merck & Co., Novartis International AG, AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim Pharma GmbH & Co. KG, Philips Respironics Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., 3M Healthcare, Omron Healthcare Inc., AptarGroup Inc., Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals plc, Mundipharma International Limited, Hovione Ltd., Vectura Group Limited, MannKind Corporation, H&T Presspart Ltd., Sunovion Pharmaceuticals Inc., Merxin Ltd., Adherium Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/soft-mist-inhalers-global-market-report

Which Region Is Projected To Lead The Soft Mist Inhalers Market During The Forecast Period?

North America was the largest region in the soft mist inhalers market in 2024. The regions covered in the soft mist inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Soft Mist Inhalers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24403&type=smp

Browse Through More Reports Similar to the Global Soft Mist Inhalers Market 2025, By The Business Research Company

Smart Inhalers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

Inhalation And Nasal Spray Generic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report

Naloxone Spray Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795